Gege Shu

449 total citations · 1 hit paper
6 papers, 262 citations indexed

About

Gege Shu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gege Shu has authored 6 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gege Shu's work include Cancer, Lipids, and Metabolism (3 papers), Ferroptosis and cancer prognosis (2 papers) and Inflammation biomarkers and pathways (1 paper). Gege Shu is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Ferroptosis and cancer prognosis (2 papers) and Inflammation biomarkers and pathways (1 paper). Gege Shu collaborates with scholars based in China. Gege Shu's co-authors include Anqi Dong, Jiaoyang Yang, Dongbao Li, Chao Dong, Jin Zhou, Weikang Li, Yuhong Wang, Lin Hu, Tao Chen and Wenhao Shen and has published in prestigious journals such as Oncogene, British Journal of Cancer and Cancers.

In The Last Decade

Gege Shu

6 papers receiving 262 citations

Hit Papers

CST1 inhibits ferroptosis and promotes gastric cancer met... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gege Shu China 4 201 154 154 36 17 6 262
Anqi Dong China 5 173 0.9× 154 1.0× 127 0.8× 32 0.9× 18 1.1× 8 245
Wanhui Wei China 7 179 0.9× 151 1.0× 160 1.0× 49 1.4× 19 1.1× 10 279
Dazhi Fu China 7 202 1.0× 143 0.9× 152 1.0× 47 1.3× 13 0.8× 11 290
Xiaonan Sheng China 10 201 1.0× 137 0.9× 193 1.3× 51 1.4× 38 2.2× 22 332
Shicheng Wang China 4 195 1.0× 118 0.8× 105 0.7× 44 1.2× 43 2.5× 10 270
Zaihuan Lin China 6 236 1.2× 157 1.0× 221 1.4× 60 1.7× 33 1.9× 8 346
Zhixing Lu China 9 270 1.3× 95 0.6× 243 1.6× 46 1.3× 18 1.1× 10 339
John Shou United States 4 229 1.1× 190 1.2× 115 0.7× 52 1.4× 17 1.0× 8 348
Xiaohan Cui China 11 176 0.9× 65 0.4× 129 0.8× 45 1.3× 30 1.8× 28 261
Yijie Hao China 7 195 1.0× 84 0.5× 152 1.0× 24 0.7× 17 1.0× 10 266

Countries citing papers authored by Gege Shu

Since Specialization
Citations

This map shows the geographic impact of Gege Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gege Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gege Shu more than expected).

Fields of papers citing papers by Gege Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gege Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gege Shu. The network helps show where Gege Shu may publish in the future.

Co-authorship network of co-authors of Gege Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Gege Shu. A scholar is included among the top collaborators of Gege Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gege Shu. Gege Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Chen, Wei‐Min, et al.. (2024). Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma. Cancer Biology & Therapy. 25(1). 2382531–2382531. 1 indexed citations
2.
Yang, Jiaoyang, Gege Shu, Tao Chen, et al.. (2023). ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis. Cancers. 16(1). 194–194. 22 indexed citations
3.
Li, Dongbao, Yunliang Wang, Anqi Dong, et al.. (2023). Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway. British Journal of Cancer. 129(8). 1261–1273. 13 indexed citations
4.
Li, Dongbao, Yuhong Wang, Chao Dong, et al.. (2022). CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 42(2). 83–98. 192 indexed citations breakdown →
5.
Shu, Gege, Huizhao Su, Shihui Lai, et al.. (2021). LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. Journal of Experimental & Clinical Cancer Research. 40(1). 45–45. 33 indexed citations
6.
Wang, Zhiqian, Huizhao Su, Shihui Lai, et al.. (2020). Research Progress on the Role of Enzymes Involved in Histone Methylation in Hepatocellular Carcinoma. 2(4). 15–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026